An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy
Clinical trial NCT01416610 · COMPLETED
Trial details
- NCT number
- NCT01416610
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-04-01
- Primary completion
- 2014-10-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.